LHC-165

Cat. No. M10846

All AbMole products are for research use only, cannot be used for human consumption.

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.

LHC-165 is an agonist of Toll-like receptor 7 (TLR7). There is potential to study solid tumors.

Molecular Weight	603.55
Formula	C29H32F2N3O7P
CAS Number	1258595-14-0
Storage	Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month

Related TLR Products
Pepinh-TRIF TFA Pepinh-TRIF TFA blocks TIR-domain-containing adapter-inducing interferon-β (TRIF) signaling by interfering with TLR-TRIF interaction.
CAY10614 CAY10614 is a potent TLR4 antagonist. CAY10614 inhibits the lipid A-induced activation of TLR4, with an IC50 of 1.675 μM.
TLR4-IN-C34-C2-COOH TLR4-IN-C34-C2-COO is a linker that incorporates TLR4 inhibitor TLR4-IN-C34. TLR4-IN-C34 inhibits TLR4 in enterocytes and macrophages, and reduces systemic inflammation in mouse models of endotoxemia and necrotizing enterocolitis.
BNT411 BNT411 is a selective TLR7 agonist that can induce the release of IFNa both in vivo and in vitro.
Rabeximod Rabeximod (ROB-803), an anti-rheumatic compound, impairs the differentiation and function of human pro-inflammatory dendritic cells and macrophages via downregulating TLR2 and TLR4 stimulation.

Catalog